The Defense Appropriation Act provides research funding for the following programs managed by the Department of Defense office of Congressionally Directed Medical Research Programs (CDMRP):
- Breast Cancer Research Program $150 Million
- Prostate Cancer Research Program $80 Million
- Ovarian Cancer Research Program $20 Million
- Neurofibromatosis Research Program $10 Million
- Tuberous Sclerosis Complex Research Program $6 Million
- Autism Research Program $8 Million
- Gulf War Illness Research Program $8 Million
- Peer Reviewed Medical Research Program $50 Million
Research topics under the Peer Reviewed Medical Research Programs are restricted to: Alcoholism, Autoimmune Diseases, Blood Cancer, Childhood Asthma, Drug Abuse, Epilepsy, Kidney Cancer, Listeria Vaccine for infectious disease and cancer, Lupus, Mesothelioma, Molecular Signatures in Tumors, Neuroblastoma, Osteoporosis and related bone disease, Paget's Disease, Pediatric Cancer, Polycystic Kidney Disease, Social Work Research, Tinnitus, West Nile Virus Vaccine.
Each announcement will be available for downloading from the Grants.gov website and CDMRP website upon its release.